TITAN BIOTECH Financial Statement Analysis
|
||
The Revenues of TITAN BIOTECH have decreased by -100.00% YoY .
The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 14.56 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
TITAN BIOTECH Last 5 Annual Financial Results
[BOM: 524717]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹124 Cr | ₹14,223,723 Cr | ₹79 Cr | ₹65 Cr | ₹57 Cr |
Expenses | ₹92 Cr | ₹9,605,092 Cr | ₹66 Cr | ₹56 Cr | ₹50 Cr |
Operating Profit (Excl OI) | ₹31 Cr | ₹4,618,631 Cr | ₹13 Cr | ₹8.91 Cr | ₹6.98 Cr |
Other Income | ₹0.94 Cr | ₹78,841 Cr | ₹0.45 Cr | ₹0.69 Cr | ₹0.45 Cr |
Interest | ₹0.87 Cr | ₹172,744 Cr | ₹2.35 Cr | ₹2.34 Cr | ₹2.39 Cr |
Depreciation | ₹2.37 Cr | ₹221,731 Cr | ₹1.80 Cr | ₹1.71 Cr | ₹0.93 Cr |
Profit Before Tax | ₹29 Cr | ₹4,270,556 Cr | ₹10 Cr | ₹5.54 Cr | ₹4.10 Cr |
Profit After Tax | ₹22 Cr | ₹3,170,529 Cr | ₹7.84 Cr | ₹3.91 Cr | ₹2.67 Cr |
Consolidated Net Profit | ₹22 Cr | ₹3,033,521 Cr | ₹7.07 Cr | ₹3.52 Cr | ₹2.54 Cr |
Earnings Per Share (Rs) | ₹30.06 | ₹26.24 | ₹36.71 | ₹8.55 | ₹4.26 |
PAT Margin (%) | 14.60 | 17.55 | 22.29 | 9.87 | 6.03 |
ROE(%) | 21.44 | 27.98 | 58.74 | 21.97 | 13.84 |
ROCE(%) | 27.40 | 33.74 | 60.80 | 21.45 | 14.88 |
Total Debt/Equity(x) | 0.06 | 0.09 | 0.21 | 0.61 | 0.74 |
Key Financials |
||
Market Cap | : | ₹ 430.9 Cr |
Revenue (TTM) | : | ₹ 161.0 Cr |
Net Profit(TTM) | : | ₹ 23.5 Cr |
EPS (TTM) | : | ₹ 28.3 |
P/E (TTM) | : | 18.4 |
Industry Peers & Returns | 1W | 1M | 1Y |
TITAN BIOTECH | 5% | 0.2% | 119.6% |
PIDILITE INDUSTRIES | -1.1% | -3.3% | 23.6% |
SOLAR INDUSTRIES INDIA | 2.5% | 3.2% | 132% |
SRF | -2.7% | -2% | 5% |
GUJARAT FLUOROCHEMICALS | -1.9% | 11.9% | 7.4% |
DEEPAK NITRITE | -1.4% | 14.2% | 31.3% |
TATA CHEMICALS | -2.8% | 0.4% | 15.5% |
GODREJ INDUSTRIES | NA | 10.1% | 98.3% |
AARTI INDUSTRIES | -1.4% | 7.7% | 32.2% |
TITAN BIOTECH Revenues
[BOM: 524717]
Y-o-Y | -100.00 % |
5 Yr CAGR | 21.14 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹124 Cr | -100.00 | |
Mar2022 | ₹14,223,723 Cr | 17,905,338.91 | |
Mar2021 | ₹79 Cr | 22.39 | |
Mar2020 | ₹65 Cr | 13.13 | |
Mar2019 | ₹57 Cr | - |
TITAN BIOTECH Operating Profit
[BOM: 524717]
Y-o-Y | -100.00 % |
5 Yr CAGR | 45.48 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹31 Cr | -100.00 | |
Mar2022 | ₹4,618,631 Cr | 34,242,419.18 | |
Mar2021 | ₹13 Cr | 51.47 | |
Mar2020 | ₹8.91 Cr | 27.58 | |
Mar2019 | ₹6.98 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -22.05 % |
5 Yr CAGR | 20.09 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 25.31% | -22.05 | |
Mar2022 | 32.47% | 91.22 | |
Mar2021 | 16.98% | 23.76 | |
Mar2020 | 13.72% | 12.74 | |
Mar2019 | 12.17% | - |
TITAN BIOTECH Profit After Tax
[BOM: 524717]
Y-o-Y | -100.00 % |
5 Yr CAGR | 70.88 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹22 Cr | -100.00 | |
Mar2022 | ₹3,033,521 Cr | 42,931,134.93 | |
Mar2021 | ₹7.07 Cr | 100.62 | |
Mar2020 | ₹3.52 Cr | 38.50 | |
Mar2019 | ₹2.54 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -16.81 % |
5 Yr CAGR | 24.74 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 14.6 % | -16.81 | |
Mar2022 | 17.55 % | -21.27 | |
Mar2021 | 22.29 % | 125.84 | |
Mar2020 | 9.87 % | 63.68 | |
Mar2019 | 6.03 % | - |
TITAN BIOTECH Earnings Per Share (EPS)
[BOM: 524717]
Y-o-Y | 14.56 % |
5 Yr CAGR | 62.98 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹30 | 14.56 | |
Mar2022 | ₹26 | -28.52 | |
Mar2021 | ₹37 | 329.36 | |
Mar2020 | ₹8.55 | 100.70 | |
Mar2019 | ₹4.26 | - |
TITAN BIOTECH Return on Capital Employed (ROCE)
[BOM: 524717]
Y-o-Y | -18.79 % |
5 Yr CAGR | 16.49 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 27.4% | -18.79 | |
Mar2022 | 33.74% | -44.51 | |
Mar2021 | 60.8% | 183.45 | |
Mar2020 | 21.45% | 44.15 | |
Mar2019 | 14.88% | - |
TITAN BIOTECH Share Price vs Sensex
Current Share Price | : | ₹519.2 |
Current MarketCap | : | ₹ 430.9 Cr |
Updated EOD on | : | May 06,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TITAN BIOTECH | 5% |
0.2% |
119.6% |
SENSEX | 0.2% |
-0.2% |
20.9% |
TITAN BIOTECH related INDICES
You may also like the below Video Courses
FAQ about TITAN BIOTECH Financials
How the annual revenues of TITAN BIOTECH have changed ?
The Revenues of TITAN BIOTECH have decreased by -100.00% YoY .
How the Earnings per Share (EPS) of TITAN BIOTECH have changed?
The Earnings Per Share (EPS) of TITAN BIOTECH has increased by 14.56 % YoY .
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs